BERGAMINI, CRISTIANA
BERGAMINI, CRISTIANA
Universita' degli Studi di MILANO
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management
2025 E. Colombo, M. Ducceschi, S. Cavalieri, M. Polignano, M. Bini, P. Ambrosini, M. De Monte, G. Montelatici, A. Russo, V. Bellia, S. Bhoori, C. Bergamini, S. Alfieri, I. Nuzzolese, A. Ottini, V. Mazzaferro, F. Raspagliesi, L. Licitra, M. Mantiero
Claudin-1 in Head and Neck Squamous Cell Carcinoma
2024 S. Cavalieri, C. Bergamini, D. Lenoci, A. Ottini, M. Lucchetta, E. Torchia, L. Licitra, L. De Cecco
Outpatient palliative care referral system (PCRS) for patients with advanced cancer: an impact evaluation protocol
2024 C. Brunelli, E. Zecca, A. Pigni, P. Bracchi, M. Caputo, S. Lo Dico, V. Fusetti, A. Tallarita, C. Bergamini, M. Brambilla, A. Raimondi, M. Niger, S. Provenzano, P. Sepe, S. Alfieri, G. Tinè, F. De Braud, A.T. Caraceni
Management of patients with skin adnexal carcinomas
2023 S. Cavalieri, C. Bergamini, S. Alfieri, C. Resteghini, I. Nuzzolese, E. Colombo, A. Ottini, L. Licitra
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
2021 S. Cavalieri, D.M. Filippini, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, R. Lombardo, I. Nuzzolese, S. Alfieri, L. Licitra, L.D. Locati
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: A randomized phase II EORTC trial
2017 P.M. Specenier, E. Remenar, J. Buter, D.L. Schrijvers, C. Bergamini, L.F.L. Licitra, A. Awada, P.M. Clement, C. Fortpied, J. Menis, J.B. Vermorken